Cyclica and Dalton have entered a collaboration to identify and develop new drug candidates using advanced computational molecular design with medicinal chemistry and drug development approaches. Cyclica will apply its in silico drug design, optimization services, and extensive databases for a number of lead molecules previously developed by Dalton Medicinal Chemistry, as well as additional compounds. Dalton Pharma Services will synthesize and manufacture quantities of selected drug candidates f...